Vaxcyte (PCVX) PT Raised to $146 at BofA Securities

October 6, 2026 6:08 AM

BofA Securities analyst Jason Gerberry raised the price target on Vaxcyte (NASDAQ: PCVX) to $146.00 (from $130.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found